Personalised Semaglutide From $179/month (287 reviews) A clinically established GLP-1 chosen for reliable weight loss with a long, proven track record
Several studies have found that taking either Januvia or Janumet is correlated to an increase of pancreatitis and pancreatic cancer
Novo Nordisk press release, 2026 The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible beneficiaries Wegovy weight-loss access at $50/month outside Part D, not counting toward the $2,100 OOP cap
This is especially important for side effects that may develop gradually or persist over time
Thursdays announcement comes as the White House is looking to demonstrate that Trump is in touch with Americans frustrations with rising costs for food, housing, health care, and other necessities